P
hase contrast and scattering-based (dark-field) x-ray imaging has been shown to be potentially revolutionizing radiological approaches to breast imaging because they are intrinsically capable of detecting subtle differences in the electron density of the tissue (phase signal) and of measuring the amount of small-angle scattering induced by microscopic density fluctuations in the specimen (scattering signal). 1Y5 Fully digital absorption-based mammography, the current clinical standard for screening and diagnosis, 6, 7 is an imperfect modality and has some limitations in sensitivity and falsepositive rates, particularly in women with generally dense breast tissue and fibroglandular tissue as well as heterogeneously dense and extremely dense breasts. 7Y10 Therefore, mammography could experience significant gains (ie, soft-tissue contrast enhancement) from x-ray phase contrast imaging as a highly sensitive, possibly cheap, and fast method, compared with existing approaches, for example, MRI 11 or tomosynthesis. 12, 13 In a preliminary work, we used grating interferometry to simultaneously record the differential phase and smallangle scattering signals of native, whole-breast samples, in addition to the conventional absorption signal. 14 We showed that the complementary information that was obtained may indeed allow improved diagnostic capabilities. In this work, we tested the hypothesis that phase contrast and dark-field signals increase the sharpness and delineation of lesions within breast tissue and may lead to a generally increased quality of radiological images. For this purpose, we designed an international, blinded reader study involving experienced breast radiologists evaluating several diagnostic aspects on mastectomy images obtained with both absorption-based clinical digital mammography and our novel phase contrast-enhanced technique.
Published results so far reported the use of synchrotron radiation 15Y18 or fixed, denatured tissue samples. 19Y21 Our work presents phase contrast images of freshly dissected mastectomy samples obtained with a conventional, low-brilliance x-ray tube evaluated on the basis of 2 blinded, prospective independent reader studies. We present a first comprehensive statistical evaluation of the imaging capabilities of this emerging x-ray technique compared with digital absorption mammography.
MATERIALS AND METHODS

Study Design
Two prospective reader studies were designed, involving mastectomy specimens of 33 patients and 6 international breast radiologists www.investigativeradiology.com 131 working in certified European breast units and screening programs. Mammograms of the freshly resected breasts were obtained with absorption-based clinical digital mammography (Mx-clin). Furthermore, absorption-based digital mammography (Mx-exp) and phase contrast-enhanced mammography (mammoDPC) were acquired simultaneously on an experimental setup as described in the study of Stampanoni et al. 14 The first study (study 1) directly compared images obtained with our experimental setup in absorption (Mx-exp) and mammoDPC using the same dose (reported to be 26.2 mSv in the study of Stampanoni et al 14 )
. This allows the a priori removal of instrument-specific characteristics and yields system-unbiased images. Craniocaudal (CC) and anteroposterior (AP) views were evaluated. Mediolateral (ML) and mediolateral oblique (MLO) views were not considered because they are almost impossible to obtain with the resected breast. Dedicated questionnaires on the general quality of the image, sharpness and delineation of the lesions, microcalcifications, skin involvement, artifacts, and general clinically relevant information were prepared. Study 1 included 9 comparative questions assessing the relative strength of phase contrast versus absorption mammograms on a 5-point Likert scale (''highly superior,'' ''superior,'' ''equivalent,'' ''inferior,'' ''highly inferior'') with respect to the previously mentioned criteria. All readers were equally instructed by the same person and independently evaluated the images presented on screen after the questionnaire.
The second study (study 2) investigated 3 types of images for all 33 mastectomy samples: Mx-clin, Mx-exp, and mammoDPC. All types of mammograms were evaluated independently as randomized blinded images by the readers. Findings of images obtained with Mxclin were compared with those of Mx-exp and mammoDPC. In study 2, only CC views are included because they correspond to the imaging plane that is regularly acquired in clinical practice. Also, for study 2, dedicated questionnaires, including 12 questions evaluating different aspects as returned by clinical, experimental, and phase contrast mammography on a multiple-point Likert scale, were prepared. All readers, again, were equally instructed by the same person and independently evaluated the randomized images presented on screen after the questionnaire. Because of experimental limitations, the dose for Mx-exp and mammoDPC was approximately 25 times larger than the dose for Mx-clin, as explained in the study of Stampanoni et al. 14 This issue does not affect study 1 (comparison of Mx-exp with mammoDPC with the same dose) and is marginally relevant for study 2. The higher dose reported for mammoDPC is mainly caused by the use of an unfiltered source, causing low-energy photons to be absorbed in the sample and interferometer but, finally, not contributing to image formation.
Both reader studies were blinded because all readers independently evaluated all mammograms taken with the 3 methods in a randomized order. In reader study 1 in particular, where Mx-exp was directly compared with mammoDPC, the randomization order also included 2 view planes (CC and AP).
Histopathological findings were available for all mastectomy samples included in the study. Identification and localization of histopathologically proven ductal carcinoma in situ (DCIS) were used to correlate image readings (positive and negative findings). All routine hematoxylin-eosin stained slides were reviewed by a gynecopathologist.
Patients Included and Sample Preparation
The local institution's ethical review board approved this study, and written informed consent was obtained from all patients. Men or women older than 18 years who presented at the department of gynecology between November 2010 and April 2012 with histopathologically confirmed unifocal, multifocal, or multicentric invasive ductal or lobular breast cancer, with and without additional DCIS, requiring modified radical mastectomy, and willing to participate in the study, were considered eligible. Patients who qualified for breast-conserving operative procedures, skin sparing, or subcutaneous mastectomy were excluded. The non-fixed tissue samples were investigated immediately after mastectomy. Breast density values according to American College of Radiology (ACR) criteria, 22 available from in vivo mammography performed on a MAMMOMAT Inspiration system (Siemens Healthcare, Erlangen, Germany) at the department of radiology of the Kantonsspital Baden 1 to 30 days before surgery, were compared with the ex vivo values provided by the study readers. Table 1 summarizes the histopathological findings and breast density values of the patients (one 55-year-old man and 32 women with a mean age of 67 years [range, 43Y93 years]) including the type of invasive carcinoma, histological grade, histopathological presence of additional DCIS, tumor centricity by histopathology, and microscopic skin infiltration.
The surgical procedure involved a modified radical mastectomy followed by a sentinel lymph node dissection and/or a complete axillary lymph node clearance, when clinically indicated. The removed breast specimen was marked with small metal clips to unequivocally identify the 3-dimensional orientation. The breast tissue samples were then mounted immediately after resection into a dedicated, cooled breast tissue holder, and within 30 to 90 minutes after the resection, Mx-clin as well as simultaneous Mx-exp and mammoDPC imaging were performed. The breast tissue holder was designed to mimic the correct orientation and adequate compression of the tissue compared with the in vivo situation.
14 Absorption mammography of the breast sample (Mx-clin) was performed with a fully digital system (MAMMOMAT Inspiration; Siemens Healthcare, Erlangen, Germany). Formalin fixation and standard histopathological examination were initiated after the mammoDPC acquisition. 
Grating Interferometry and mammoDPC Measurement
A Talbot-Lau 23 grating interferometer with a standard x-ray tube and a commercial flat panel detector (pixel size, 50 Â 50 Km) was set up at the Paul Scherrer Institute in Villigen, Switzerland. We used Seifert ID 3000 x-ray generator, an unfiltered tungsten line focus tube (operated at 40 kilovolt [peak] with a mean energy of 28 keV and a current of 25 mA), and a 3 grating interferometer (with periods of p 0 = 14 Km, p 1 = 3.5 Km, and p 2 = 2.0 Km, respectively). The source-to-detector distance was 1.6 m. Additional details on the experimental system are given in the study of Stampanoni et al. 14 Absorption, phase, and scattering signals were recorded simultaneously using a phase-stepping approach, where the absorption grating is translated perpendicular to the grating direction by a fractional distance of the grating period, and a Fourier analysis of the resulting intensity curve returned the previously mentioned signals. 24 After the operation, Mx-clin was performed in the clinic, whereas Mx-exp and mammoDPC were performed within 30 to 90 minutes after transport (15-km distance) at the Paul Scherrer Institute in Villigen, Switzerland. The field of view of the Mx-exp and mammoDPC images is limited to 5 Â 5 cm 2 , thus requiring multiple snapshots to be tiled together to cover the size of the resected breast.
Imaging Protocol and Image Processing
The raw Mx-exp images were processed with the Philips UNIQUE algorithm, 25 which is used in commercial mammography systems. This ensures that the quality of the processed images corresponds to the clinical standard. During the mammoDPC data acquisition, one of the interferometer gratings is moved perpendicular to the grating lines within at least 1 gratings period (phase-stepping approach). For each pixel on the detector, a quasi-sine intensity curve is recorded. The absorption, differential phase, and scattering signals are obtained by a retrieving algorithm 24, 26 operating on phase-stepping curves with and without the object.
The retrieved signals have been effectively fused into a single and more informative image. The fusion procedure involves merging the high frequencies of the differential phase signal into the absorption image by a dedicated algorithm. 28 The inclusion of the scattering image is achieved by fusing it into the merged image by adaptive, multilevel thresholding. 28 It is based on a ''decompose-process and fusereconstruct'' approach. The absorption, differential phase, and scattering signals are first decomposed into multiple levels and bands, which represent image information at different scales and frequencies, with the help of wavelets decomposition. Furthermore, an intraband processing first enhances the local signal-to-noise ratio; then, the interband processing weights each band by considering its characteristics and relative contributions. Finally, the resulting fusion image shows a similar appearance to that of a conventional mammogram but contains significantly enhanced features' details.
Statistical Analysis
The statistical analysis was done by the statistical consulting service of the Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland. The Wilcoxon signed rank test was used for the qualitative analysis of subjective preference score in both reader studies. IBM Statistical Package for the Social Sciences Statistics 20 (SPSS Inc, Chicago, IL) was used for the descriptive and pairwise comparisons (Wilcoxon signed rank test) of image types. Stata 11.2 (StataCorp, Lakeway Drive, TX) was used for the computation of J values to evaluate interreader variability. For all statistical analyses, a 2-tailed P G 0.05 was considered to indicate a statistically significant difference. For reader study 1, a Bonferroni correction was made to consider the 9 comparisons per view; therefore, P e 0.05/9 approximately equal to 0.005 was considered significant. For reader study 2, a total of 2 comparisons per question were considered, resulting in P e 0.05/2 equal to 0.025 for significance. Interobserver agreement between the readers was calculated by weighted J statistics. The J values in the ranges 0.00 to 0.20, 0.21 to 0.40, 0.41 to 0.60, 0.61 to 0.80, and 0.81 to 1.00 were considered to represent slight agreement, fair agreement, moderate agreement, substantial agreement, and almost perfect agreement, respectively.
RESULTS
Reader Study 1
The results of the statistical analysis revealed the general quality of the mammoDPC images to be significantly superior than that of the Mx-exp based images (P G 0.001; median of 2 with an interquartile range [IQR] of 2-3, with 2 being ''superior'' and 3 being ''equivalent''). Furthermore, the sharpness and lesion delineation as well as the general visibility of calcifications were rated as significantly more assessable on mammoDPC than on Mx-exp (P G 0.001; median of 2 with an IQR of 2-3, with 2 being ''superior'' and 3 being ''equivalent''). MammoDPC images resulted in a sharper delineation of anatomic components of the specimens (surface structures) when evaluating the periphery of the images (P G 0.001; median of 2 with an IQR of 2-2, with 2 being ''superior''), with 75% of the readings indicating that mammoDPC was better than Mx-exp. Table 2 summarizes the results.
Reader Study 2
Spiculations could be significantly better identified in mammoDPC images compared with Mx-clin (P G 0.015), whereas Mx-exp images were shown to be directly comparable with the Mx-clin mammograms (P G 0.076) (Figs. 1 and 2C, D) . Blood vessel visibility was lower in the mammoDPC and Mx-exp images, when compared with the Mx-clin mammograms (Table 3) .
Microcalcifications
The presence of clusters of suspicious microcalcifications was similarly observed in mammoDPC with respect to Mx-exp. No statistically significant difference (P = 0.2) was observed (Table 3) . On the other hand, significantly superior findings of calcification sharpness (Table 2) were seen in mammoDPC compared with Mx-exp (P G 0.001; median of 2 with an IQR of 2-3, with 2 being ''superior'' and 3 being ''equivalent'') (Figs. 1A, B and 2A, B) . G0.015 § *P G 0.005 is considered to be significant with Bonferroni correction. †2 being ''superior'' and 3 being ''equivalent'' quality. ‡4 being ''11% to 20% superior'' and 5 being ''1% to 10% superior.'' §This criterion was evaluated in study 2. P G 0.025 is significant with the Bonferroni correction.
IQR indicates interquartile range; mammoDPC, phase contrast-enhanced mammography.
Ductal Carcinoma In Situ
We analyzed the ability of Mx-clin, Mx-exp, and mammoDPC imaging to detect microcalcifications interpreted by the readers as suggestive of DCIS. Although the results were not statistically significant (Table 3) , we observed that mammoDPC returned more true findings (64%, positives and negatives) than did Mx-exp (56%) and Mx-clin (59%) when related to the criterion standard provided by the histopathological examination. It must be stated, however, that we obtained a considerable amount of false negatives (36%, 37%, and 29% for Mx-clin, Mx-exp, and mammoDPC, respectively) for this diagnostic question, with a moderate level of interreader agreement (J = 0.400). Because of the inclusion criteria of the study, there was only 1 patient with no radiological signs of invasive carcinoma. This patient had a very small invasive carcinoma (pT1a), surrounded by an extended DCIS. All other patients showed histopathological findings consistent with an invasive carcinoma of pT1b or higher. This was successfully indicated by all 3 methods, with 91% of true positives for mammoDPC compared with 87% for both Mx-exp and Mx-clin. This difference was not statistically significant and the level of interreader agreement was moderate (J = 0.546).
Artifacts
Minor or no imaging artifacts (like abnormal edge enhancement) were detected in most of the readings (94%, 97%, 82% for Mx-clin, Mx-exp, and mammoDPC, respectively). More generally, mammoDPC generated significantly stronger artifacts than did Mx-clin (P G 0.001), whereas it was comparable with Mx-exp (P = 0.047 with a threshold of 0.025 for significance, according to Bonferroni). The presence of new types of artifacts, generated by the intrinsic physics of the novel signals and the experimental arrangement, led to a slight change in interpretation, but it did not affect the diagnostic content. Among the pictures showing artifacts (disregarding air bubbles and non-tissue related structures due to the experimental arrangement), 75% of the readings classified those artifacts in mammoDPC as significantly stronger than those in Mx-clin (P G 0.001; an IQR of 2-2, with 2 being ''stronger'' and 3 being ''equivalent''). In reader study 2, air bubbles or other non-tissue related structures were identified for all mammography techniques by all readers. Specifically, with Mx-clin, air bubbles were visible in 88% of the readings, whereas Mx-exp and mammoDPC showed these artifacts in 95% and 99% of the readings, respectively. This difference was not statistically significant.
Skin Infiltration
Approximately one third of the tumors showed histopathologically confirmed skin infiltration. No significant differences were found in the abilities of the 3 approaches to detect signs of skin infiltration (skin retraction and/or skin thickening; Table 3 ). However, the number of cases was insufficient for a sound statistical analysis. The level of interreader agreement for this evaluation was fair (J = 0.236).
Potentially Clinically Relevant Information
One of the most challenging questions was related to the amount of potentially clinically relevant information provided by the novel method to the readers according to their individual judgments weighted by their expertise. The readers compared all pairs of images and indicated an amount of potentially superior or inferior clinically relevant information of Mx-exp compared with mammoDPC. Excluding equivalent findings (72%) resulted in a significant superiority of the mammoDPC technique with respect to Mx-exp (P G 0.001; median of 5 with an IQR of 4-5, with 5 being ''1% to 10% superior'' and 4 being ''11% to 20% superior'').
The ACR breast density values evaluated among all 3 imaging protocols were not significantly different from those of in vivo mammography (considered as the criterion standard), demonstrating that, as 
DISCUSSION
The mammoDPC images were preferred over the Mx-clin and Mx-exp mammograms with respect to potential clinical relevance, according to the general quality of the mammoDPC images, sharpness and lesion delineation as well as the general visibility of calcifications, sharper delineation of anatomic components of the specimen, and spiculation visibility. This preference was statistically significant when the number of equivalent findings was excluded from the analysis. This result can be explained by the fact that the study was carried out exclusively with mastectomy samples, that is, where a malignant process was previously identified.
The identification of DCIS in the mammograms proved to be difficult for all readers. Because no patient with only DCIS was included in the study, the diagnostic challenge was to identify DCIS within or surrounding an invasive carcinoma.
Blood vessel visibility was found to be lower in mammoDPC and Mx-exp than in Mx-clin (P = 0.017 for mammoDPC vs Mx-clin with a threshold of 0.025 for significance, according to Bonferroni; Table 3 ). This evidence may also be a consequence of the study design. The Mx-clin mammogram was taken only a few minutes after the resection, when blood was still in the vessels and could contribute to the contrast. The Mx-exp and mammoDPC were performed within 30 to 90 minutes, but during this time, the remaining blood redistributed within the sample. As the sample is mounted into the dedicated breast holder with a compression that simulates clinical standards, a loss of blood occurs and affects the contrast in the subsequent investigation. This interpretation is supported by the finding that mammoDPC and Mx-exp showed comparable readings with respect to blood vessel visibility (P = 0.25).
The results of the evaluation of signs for skin infiltration did not reveal any significant differences between the 3 methods. Therefore, mammoDPC does not affect, either positively or negatively, the ability to identify signs of skin infiltration (Table 3) .
Existing scar tissue due to previous surgical interventions consists of a different extracellular matrix structure 29, 30 resulting from a change in the quantity and type of collagens and noncollagenous components, when compared with regular breast tissue, and is well detectable by mammoDPC, as shown in Figure 3 . This is caused by the high sensitivity of the technique to the scattering power of the investigated sample. Similarly, nontissue material present in the breast such as stitches that usually consist of strongly scattering textile wires cannot be detected by Mx-clin but is strongly enhanced by mammoDPC.
Study Limitations
Because of the inclusion criteria of our study design, 33 breast samples of all patients screened during the allocated time frame have been included. Despite being blinded, the readers quickly learned how to differentiate between Mx-clin/Mx-exp and mammoDPC because of the striking sharpness increase of the edges within the mammoDPC images. This was unavoidable because mammoDPC is expected to increase sharpness in general. The ''tiling'' artifact due to the limited field of view observed in both the Mx-exp and mammoDPC images was not reported to be a disturbing factor in the reading process. Nevertheless, an ongoing study (unpublished) demonstrates that gratings can be successfully stitched to cover a much larger field of view, eliminating every tiling artifact in future experiments. Furthermore, the readers may be biased by the fact that they had to read images of mastectomy samples because, as a consequence of the study design, no resected whole-breast sample without invasive carcinoma was included. The strong enhancement of fine details, due to the boost in high-frequency content by the differential phase contrast, 28 was sometimes ranked as an artifact. This may have arisen because the radiologists involved in the study were trained to interpret absorption-based mammograms. We are aware that radiologists interpreting mammograms must be particularly attuned to the detection of the presence of microcalcifications, which can also be considered high-frequency image data. However, microcalcifications are normally identified as bright, localized spots, whereas the previously mentioned frequency boosting happens all over the image. Also, there was no presence of microcalcifications but only subtle tissue changes. The mean glandular dose for a 4.5 cm thick breast sample was measured with a PTW-UNIDOS instrument to be 26.2 mSv for both mammoDPC and Mx-exp, as described in the study of Stampanoni et al. 14 The high delivered dose (25 times higher as recommended in the European guidelines 31 ) is mainly caused by the nonoptimized design of the experimental instrument. Because of its low photon efficiency, the delivered dose is deliberately tuned higher to be able to generate Mx-exp images with similar image quality to that of Mx-clin images for fair comparison. With an optimized design of each component, as described in the study of Stampanoni et al, 14 the dose could be reduced by more than 1 order of magnitude while maintaining the same image quality.
With this study, we have demonstrated, for the first time, that phase contrast-enhanced mammograms of mastectomy samples obtained using a conventional x-ray source have significantly higher diagnostic content compared with that of classically digital absorption-based images for the evaluated criteria as summarized in Table 2 . Differential phase contrast mammography may have the potential to advance as a new diagnostic tool and eventually outperform recently introduced approaches, for instance, the use of monochromatic x-rays for digital mammography. 32 So far, no other imaging technology is capable of exploiting x-ray differential phase and scattering signals to significantly improve soft tissue imaging. These results are promising toward the use of phase contrast grating interferometry in vivo in a clinical setting. On the basis of our experience, 14 we expect this technology to be further developed and integrated into an optimized prototype performing at dose depositions lower or (at worst) comparable with present, approved instruments. The complementary information provided by phase and scattering-enhanced mammograms delivers images of generally superior quality. As a consequence, this technique has the potential to improve radiological breast diagnostics.
